America’s Health Insurance Plans lobby said the rule seeking to claw back billions of dollars from health insurers is unlawful and fatally flawed.
The decision is a win for drug manufacturers Sanofi, Novo Nordisk and AstraZeneca. The companies sued the HHS after regulators ordered them to stop restricting sales of 340B drugs to contract pharmacies.
The Biden administration warned that hospitals are at risk of revenue losses and care delays if the public health emergency ends abruptly.
Negative margins and heightened labor expenses persisted for hospitals in 2022, causing them to suffer their worst financial year since the pandemic began, according to the report.
The rule also would create an option allowing people enrolled in health coverage or plans provided by “objecting entities” to obtain contraceptive coverage.
CMS to crack down on Medicare Advantage audits, poised to claw back billions of dollars from insurers
Federal regulators have raised concerns about alleged payment abuses in the MA program for years, specifically for those tied to risk adjustments.
State officials began investigating Express Scripts in April after receiving multiple complaints from an independent pharmacy association over the Cigna-owned PBM’s handling of claims.
“It’s more important to do this right than to do it fast,” Minnesota’s Chief Deputy Attorney General John Keller said regarding the deal.
A rise in union activity also may persist as the sector continues recovering from the COVID-19 pandemic.
The pandemic forced us to rethink how to leverage technology and data to augment resources and shift to new adoption models for better patient experiences.